Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease

DMM Disease Models and Mechanisms

Volumn 5, Issue 2, 2012, Pages 248-258

  Friedrich, Timo ^a   Lambert, Aaron M ^b   Masino, Mark A ^b   Downes, Gerald B ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMINO ACID; DIHYDROLIPOAMIDE BRANCHED CHAIN TRANSACYLASE E2; GLUTAMIC ACID; MITOCHONDRIAL ENZYME; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; GENE MUTATION; LOCOMOTION; MAPLE SYRUP URINE DISEASE; MOTOR DYSFUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD; ZEBRA FISH;

ACYLTRANSFERASES; AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BASE SEQUENCE; BRAIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMIC ACID; HUMANS; LARVA; MAPLE SYRUP URINE DISEASE; MUTATION; NEUROMUSCULAR DISEASES; RNA, MESSENGER; SWIMMING; ZEBRAFISH; ZEBRAFISH PROTEINS;

ACER; DANIO RERIO;

EID: 84858010884     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008383     Document Type: Article

References (42)

1. Abrams, E. W. and Mullins, M. C. (2009). Early zebrafish development: it's in the maternal genes. Curr. Opin. Genet. Dev. 19, 396-403.
2. Bill, B. R., Petzold, A. M., Clark, K. J., Schimmenti, L. A. and Ekker, S. C. (2009). A primer for morpholino use in zebrafish. Zebrafish 6, 69-77.
3. Chuang, D. T., Chuang, J. L. and Wynn, R. M. (2006). Lessons from genetic disorders of branched-chain amino acid metabolism. J. Nutr. 136 Suppl. 1, 243S-249S.
4. Chuang, D. T., Wynn, R. M. and Shih, V. E. (2008). Maple syrup urine disease (branched-chain ketoaciduria). In The Online Metabolic And Molecular Bases Of Inherited Diseases (ed. D. Valle, A. L. Beaudet, B. Vogelstein, K. W. Kinzler, S. E. Antonarakis and A. Ballabio), Chapter 87, pp. 1-42. New York: McGraw-Hill.
5. Coitinho, A. S., de Mello, C. F., Lima, T. T., de Bastiani, J., Fighera, M. R. and Wajner, M. (2001). Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res. 894, 68-73.
6. Downes, G. B. and Granato, M. (2004). Acetylcholinesterase function is dispensable for sensory neurite growth but is critical for neuromuscular synapse stability. Dev. Biol. 270, 232-245.
7. Downes, G. B. and Granato, M. (2006). Supraspinal input is dispensable to generate glycine-mediated locomotive behaviors in the zebrafish embryo. J. Neurobiol. 66, 437-451.
8. Drapeau, P., Ali, D. W., Buss, R. R. and Saint-Amant, L. (1999). In vivo recording from identifiable neurons of the locomotor network in the developing zebrafish. J. Neurosci. Methods 88, 1-13.
9. Eaton, R. C., Farley, R. D., Kimmel, C. B. and Schabtach, E. (1977). Functional development in the Mauthner cell system of embryos and larvae of the zebra fish. J. Neurobiol. 8, 151-172.
10. Ekker, S. C. (2008). Zinc finger-based knockout punches for zebrafish genes. Zebrafish 5, 121-123.
11. Geisler, R., Rauch, G. J., Geiger-Rudolph, S., Albrecht, A., van Bebber, F., Berger, A., Busch-Nentwich, E., Dahm, R., Dekens, M. P., Dooley, C. et al. (2007). Large-scale mapping of mutations affecting zebrafish development. BMC Genomics 8, 11.
12. Gleason, M. R., Armisen, R., Verdecia, M. A., Sirotkin, H., Brehm, P. and Mandel, G. (2004). A mutation in serca underlies motility dysfunction in accordion zebrafish. Dev. Biol. 276, 441-451.
13. Granato, M., van Eeden, F. J., Schach, U., Trowe, T., Brand, M., Furutani-Seiki, M., Haffter, P., Hammerschmidt, M., Heisenberg, C. P., Jiang, Y. J. et al. (1996). Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development 123, 399-413.
14. Herring, W. J., McKean, M., Dracopoli, N. and Danner, D. J. (1992). Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease. Biochim. Biophys. Acta 1138, 236-242.
15. Hirata, H., Saint-Amant, L., Waterbury, J., Cui, W., Zhou, W., Li, Q., Goldman, D., Granato, M. and Kuwada, J. Y. (2004). Aaccordion, a zebrafish behavioral mutant, has a muscle relaxation defect due to a mutation in the ATPase Ca2+ pump SERCA1. Development 131, 5457-5468.
16. Hirata, H., Saint-Amant, L., Downes, G. B., Cui, W. W., Zhou, W., Granato, M. and Kuwada, J. Y. (2005). Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit. Proc. Natl. Acad. Sci. USA 102, 8345-8350.
17. Homanics, G. E., Skvorak, K., Ferguson, C., Watkins, S. and Paul, H. S. (2006). Production and characterization of murine models of classic and intermediate maple syrup urine disease. BMC Med. Genetics 7, 33.
18. Kimmel, C. B., Patterson, J. and Kimmel, R. O. (1974). The development and behavioral characteristics of the startle response in the zebra fish. Dev. Psychobiol. 7, 47-60.
19. Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253-310.
20. Legendre, P. and Korn, H. (1994). Glycinergic inhibitory synaptic currents and related receptor channels in the zebrafish brain. Eur. J. Neurosci. 6, 1544-1557.
21. Link, V., Shevchenko, A. and Heisenberg, C. P. (2006). Proteomics of early zebrafish embryos. BMC Dev. Biol. 6, 1.
22. Masino, M. A. and Fetcho, J. R. (2005). Fictive swimming motor patterns in wildtype and mutant larval zebrafish. J. Neurophysiol. 93, 3177-3188.
23. McKeown, K. A., Downes, G. B. and Hutson, L. D. (2009). Modular laboratory exercises to analyze the development of zebrafish motor behavior. Zebrafish 6, 179-185.
24. Mendelsohn, B. A. and Gitlin, J. D. (2008). Coordination of development and metabolism in the pre-midblastula transition zebrafish embryo. Dev. Dyn. 237, 1789-1798.
25. Morton, D. H., Strauss, K. A., Robinson, D. L., Puffenberger, E. G. and Kelley, R. I. (2002). Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 109, 999-1008.
26. Olson, B. D., Sgourdou, P. and Downes, G. B. (2010). Analysis of a zebrafish behavioral mutant reveals a dominant mutation in atp2a1/SERCA1. Genesis 48, 354-361.
27. Parichy, D. M., Elizondo, M. R., Mills, M. G., Gordon, T. N. and Engeszer, R. E. (2009). Normal table of postembryonic zebrafish development: staging by externally visible anatomy of the living fish. Dev. Dyn. 238, 2975-3015.
28. Pei, W., Kratz, L. E., Bernardini, I., Sood, R., Yokogawa, T., Dorward, H., Ciccone, C., Kelley, R. I., Anikster, Y., Burgess, H. A. et al. (2010). A model of Costeff Syndrome reveals metabolic and protective functions of mitochondrial OPA3. Development 137, 2587-2596.
29. Saint-Amant, L. and Drapeau, P. (1998). Time course of the development of motor behaviors in the zebrafish embryo. J. Neurobiol. 37, 622-632.
30. Silberman, J., Dancis, J. and Feigin, I. (1961). Neuropathological observations in maple syrup urine disease: branched-chain ketoaciduria. Arch. Neurol. 5, 351-363.
31. Skvorak, K. J., Hager, E. J., Arning, E., Bottiglieri, T., Paul, H. S., Strom, S. C., Homanics, G. E., Sun, Q., Jansen, E. E., Jakobs, C. et al. (2009a). Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim. Biophys. Acta 1792, 1004-1010.
32. Skvorak, K. J., Paul, H. S., Dorko, K., Marongiu, F., Ellis, E., Chace, D., Ferguson, C., Gibson, K. M., Homanics, G. E. and Strom, S. C. (2009b). Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol. Ther. 17, 1266-1273.
33. Strauss, K. A. and Morton, D. H. (2003). Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr. Treat. Options Neurol. 5, 329-341.
34. Strauss, K. A., Mazariegos, G. V., Sindhi, R., Squires, R., Finegold, D. N., Vockley, G., Robinson, D. L., Hendrickson, C., Virji, M., Cropcho, L. et al. (2006). Elective liver transplantation for the treatment of classical maple syrup urine disease. Am. J. Transplant. 6, 557-564.
35. Strauss, K. A., Wardley, B., Robinson, D., Hendrickson, C., Rider, N. L., Puffenberger, E. G., Shelmer, D., Moser, A. B. and Morton, D. H. (2010). Classical maple syrup urine disease and brain development: principles of management and formula design. Mol. Genet. Metab. 99, 333-345.
36. Tay, T. L., Lin, Q., Seow, T. K., Tan, K. H., Hew, C. L. and Gong, Z. (2006). Proteomic analysis of protein profiles during early development of the zebrafish, Danio rerio. Proteomics 6, 3176-3188.
37. Thisse, C. and Thisse, B. (2008). High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat. Protoc. 3, 59-69.
38. Wang, M., Wen, H. and Brehm, P. (2008). Function of neuromuscular synapses in the zebrafish choline-acetyltransferase mutant bajan. J. Neurophysiol. 100, 1995-2004.
39. Zhang, Y. Z., Ouyang, Y. C., Hou, Y., Schatten, H., Chen, D. Y. and Sun, Q. Y. (2008). Mitochondrial behavior during oogenesis in zebrafish: a confocal microscopy analysis. Dev. Growth Differ. 50, 189-201.
40. Zinnanti, W. J., Lazovic, J., Griffin, K., Skvorak, K. J., Paul, H. S., Homanics, G. E., Bewley, M. C., Cheng, K. C., Lanoue, K. F. and Flanagan, J. M. (2009). Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132, 903-918.
41. Zon, L. I. and Peterson, R. (2010). The new age of chemical screening in zebrafish. Zebrafish 7, 1.
42. Zottoli, S. J. and Faber, D. S. (2000). The Mauthner cell: what has it taught us? Neuroscientist 6, 26-38.